Oral chemotherapy (undisclosed)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Oral chemotherapy (undisclosed), covering 2025-07-18 to 2025-07-18. Get the full timeline:
Most recent: Clinical Trial Update: A Randomized, Open-label, Multi-center Phase III Study Comparing the Efficacy of Oral Chemotherapy Combined With Trastuzumab Versus Paclitaxel Combined With Trastuzumab in the Adjuvant Treatment of HER2-positive, Lymph Node-negative Early Breast Cancer Patients(ORCHID-PLUS) [Phase 3]